American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access
Panacea Biotec receives LoA from CMSS
The FDA is also reviewing the application under its Real-Time Oncology Review (RTOR) program and Project Orbis
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
Subscribe To Our Newsletter & Stay Updated
